Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-15

Clinical Trial Update: Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing low-dose aspirin to prevent preterm preeclampsia in high-risk pregnant patients is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (low-dose) (acetylsalicylic acid)

Snippet

Sponsor: University of Virginia | Conditions: Preeclampsia, Pregnancy Related | Phase 4 | Status: ACTIVE_NOT_RECRUITING